{"id":"W2944211448","doi":"10.1158/1538-7445.sabcs18-p4-13-06","title":"Abstract P4-13-06: Real-world experience using exemestane and everolimus in patients with hormone receptor positive/HER2 negative breast cancer with and without prior CDK4/6 inhibitor exposure","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Exemestane; Aromatase inhibitor; Internal medicine; Breast cancer; Discontinuation; Oncology; Lapatinib; Anastrozole; Everolimus; Cancer; Trastuzumab; Tamoxifen","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002865276,0.0003857566,0.0006112063,0.0003720068,0.0001917932,0.00007511911,0.0001443162,0.0001114313,0.0002587441],"category_scores_gemma":[0.00002217335,0.0002853048,0.00002443011,0.0009270581,0.00080899,0.0006377018,0.0001225526,0.0007739522,0.000005138941],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001129085,"about_ca_system_score_gemma":0.000673073,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01090374,"about_ca_topic_score_gemma":0.002850311,"domain_scores_codex":[0.9967101,0.0001108488,0.0003288607,0.0009045557,0.00109317,0.0008524532],"domain_scores_gemma":[0.9981151,0.000114546,0.0001669053,0.0004245277,0.0008037002,0.0003752508],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01811224,0.0001722669,0.9325091,0.0001978735,0.0001200284,0.00002391544,0.004988487,0.00004599293,0.0297415,0.000007300011,0.00001653718,0.0140648],"study_design_scores_gemma":[0.01066294,0.0009774036,0.979386,0.002242383,0.00002624951,0.00002489687,0.001585602,0.00002759341,0.004523143,0.00001017458,0.0001614057,0.0003722028],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956732,0.001380902,0.000007298315,0.0003706928,0.0000592005,0.002104207,0.0001700922,0.00003925253,0.0001951052],"genre_scores_gemma":[0.9973789,0.0006123264,0.0007575777,0.0001250733,0.0001893505,0.0003624313,0.0000138248,0.0001070357,0.0004534861],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04687694,"threshold_uncertainty_score":0.9999599,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02472914254492935,"score_gpt":0.3533755591893351,"score_spread":0.3286464166444057,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}